Webinar: A Presentation and Patient Roundtable Discussion
The following webinar was presented March 31, 2021.
This webinar focused on real-life experiences and helped to demonstrate how to use PHENPath.com to navigate your prostate cancer journey.
Webinar: Understanding where you are on your prostate cancer journey! Presented by PHENPath.com and the Prostate Health Education Network
— PHENPath.com helps Prostate Cancer patients understand their treatment pathways and treatment options. Prostate Cancer diagnosis, Treatment Options, PSA Recurrence after Radical Prostatectomy, Progression After Radiation, Hormone Sensitive Cancer, Castration Resistent Cancer, Low Risk, Very Low Risk, Intermediate Risk, High Risk, Very High Risk, Metastatic, Regional, Prostate Cancer Diagnosis, Testing, Treatment Therapies, Understanding your Risk Level
Recent Posts
The Jackson, Mississippi Prostate Cancer Disparity Rally mobilized leaders to record prostate cancer awareness messages.
PHENPath.com – Empowering Patients
PHEN Supports Talapro-3 Clinical Trial
The FDA approves a new prostate cancer combination treatment based upon a successful clinical trial- If you are experiencing PSA recurrence after surgery, PHENPath.com provides information about available treatment options as set forth by NCCN Guidelines®
